Thermo Fisher Scientific expands St. Louis manufacturing for complex biologic treatments
Increased capability to produce medicines for challenging diseases including cancer
Increased capability to produce medicines for challenging diseases including cancer
The company had submitted a comprehensive Corrective and Preventive Action (CAPA) plan in September 2022
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
Expanding to states like Maharashtra, Andhra Pradesh, Telangana, and Manipur while marking the significant milestone in its journey towards providing accessible healthcare services
Dozee Pro Ex will offer Ambulatory patient monitoring for a seamless continuum of patient monitoring across different care settings
Dr. Singh proposes upskilling medicos with AI, Quantum and other newer technologies to meet the changing requirements of patient care
Lokavant provides clinical trial intelligence
VaxTRIALS Adds a New Latin America Base and Greater Vaccine Research Depth
The World Homoeopathy Day commemorates the birth anniversary of Dr Samuel Hahnemann on 10th of April
Subscribe To Our Newsletter & Stay Updated